BANGALORE Males: The leading sites of cancer were: lung (10.6%), stomach (7.6%), prostate (7.0%), oesophagus (6.0%) and brain, NS (5.0%). The respective CR and AAR per 100,000 population for these sites were: lung (8.8 and 11.7), stomach (6.3 and 8.2), prostate (5.8 and 8.2), oesophagus (5.0 and 6.7) and brain, NS (4.1 and 4.6). Females: Breast (27.5%) was the leading site of cancer in Bangalore registry area. The other leading sites were cervix uteri (12.3%), ovary (5.3%), thyroid (4.0%) and mouth (3.9%). The respective CR and AAR per 100,000 population for the sites were: breast (29.3 and 34.4), cervix uteri (13.1 and 15.3), ovary (5.6 and 6.5), thyroid (4.3 and 4.1) and mouth (4.2 and 5.4).
DELHI Males: The leading sites of cancer were: lung (10.5%), mouth (6.9%), prostate (6.7%), tongue (6.5%) and larynx (5.7%). The respective CR and AAR per 100,000 for the sites were: lung (11.8 and 17.2), mouth (7.8 and 9.5), prostate (7.6 and 12.4), tongue (7.3 and 9.3) and larynx (6.4 and 8.9). Females: The leading cancer sites among females were: breast (28.6%) followed by cervix uteri (10.8%), gall bladder (7.9%), ovary (7.2%) and corpus uteri (3.5%). The respective CR and AAR per 100,000 population for the sites were: breast (34.8 and 41.0), cervix uteri (13.2 and 15.5), gall bladder (9.6 and 11.8), ovary (8.7 and 10.0) and corpus uteri (4.3 and 5.5).
MUMBAI Males: The leading sites of cancer were: lung (10.4%), mouth (8.8%), prostate (7.9%), liver (5.7%) and tongue (4.9%). The respective CR and AAR per 100,000 population for the sites were: lung (10.2 and 12.4), mouth (8.6 and 9.1), prostate (7.7 and 9.8), liver (5.6 and 6.6) and tongue (4.8 and 5.1). Females: The leading cancer sites among females were: breast (28.8%) followed by cervix uteri (7.7%), ovary (6.9%), lung (5.0%) and gall bladder (3.5%). The respective CR and AAR per 100,000 population for the sites were: breast (33.6 and 33.6), cervix uteri (9.0 and 9.0), ovary (8.1 and 8.1), lung (5.8 and 6.0) and gall bladder (4.1 and 4.1).
MANIPUR STATE Males: The leading sites of cancer were: lung (17.2%), stomach (7.1%), nasopharynx (5.9%), oesophagus (5.2%) and NHL (4.7%). The respective CR and AAR per 100,000 population for the sites were: lung (7.8 and 11.4), stomach (3.2 and 4.4), nasopharynx (2.7 and 3.4), oesophagus (2.4 and 3.3) and NHL (2.1 and 2.6). Females: The leading cancer sites among females were: breast (15.3%) followed by lung (13.9%), cervix uteri (9.2%), thyroid (8.0%) and ovary (5.7%). The respective CR and AAR per 100,000 population for the sites were: breast (8.6 and 9.7), lung (7.8 and 10.9), cervix uteri (5.1 and 6.1), thyroid (4.5 and 4.9) and ovary (3.2 and 3.5).
AURANGABAD Males: The leading sites of cancer among males were: lung (12.3%), mouth (11.8%), tongue (9.6%), oesophagus (6.8%) and larynx (6.6%). The respective CR and AAR of the sites per 100,000 population for the sites were: lung (7.0 and 9.7), mouth (6.7 and 7.4), tongue (5.5 and 6.3), oesophagus (3.8 and 5.4) and larynx (3.7 and 5.2). Females: The leading sites of cancer among females were: breast (30.6%) followed by cervix uteri (19.9%), ovary (6.2%), lung (4.4%), oesophagus (3.3%) and tongue (3.3%). The respective CR and AAR per 100,000 population were: breast (18.5 and 22.6), cervix uteri (12.0 and 14.3), ovary (3.7 and 4.7), lung (2.6 and 3.4), oesophagus (2.0 and 2.6) and tongue (2.0 and 2.4).
KOLKATA Males: The leading sites of cancer were: lung (18.9%), prostate (8.2%), mouth (6.9%), tongue (5.5%) and larynx (5.4%). The respective CR and AAR per 100,000 population for the sites were: lung (22.4 and 19.1), prostate (9.8 and 8.2), mouth (8.2 and 6.8), tongue (6.5 and 5.4) and larynx (6.4 and 5.6). Females: The leading cancer sites among females were: breast (25.4%) followed by cervix uteri (10.1%), ovary (7.8%), gall bladder (7.4%) and lung (7.1%). The respective CR and AAR per 100,000 population for the sites were: breast (30.7 and 25.5), cervix uteri (12.2 and 10.4), ovary (9.4 and 8.0), gall bladder (8.9 and 7.7) and lung (8.6 and 7.4).
PUNE Males: The leading sites of cancer were: mouth (10.6%), lung (8.3%), prostate (7.3%), tongue (5.7%) and NHL (4.7%). The respective CR and AAR per 100,000 population for the sites were: mouth (6.6 and 7.7), lung (5.2 and 6.9), prostate (4.5 and 6.3), tongue (3.6 and 4.0) and NHL (2.9 and 3.7). Females: The leading cancer sites among females were: breast (31.4%) followed by cervix uteri (10.6%), ovary (7.4%), mouth (4.4%) and lung (4.3%). The respective CR and AAR per 100,000 population for the sites were: breast (23.4 and 26.4), cervix uteri (7.8 and 9.0), ovary (5.5 and 6.3), mouth (3.3 and 3.7) and lung (3.2 and 3.9).